サマリー

市場分析と洞察。メサラジンの世界市場
2020年のメサラジンの世界市場規模は160.54百万米ドルで、予測期間中に4.44%のCAGRで成長し、2027年には210.03百万米ドルになると予測されています。本調査では、2021年を基準年とし、2021年から2027年を予測期間として、メサラジンの市場規模を推定しています。
世界のメサラジンの範囲と市場規模
メサラジン市場は、地域別、国別、企業別、タイプ別、アプリケーション別、販売チャネル別に分類されています。世界のメサラジン市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの地域別、国別、企業別、タイプ別、アプリケーション別、販売チャネル別の売上高、収益、予測を中心に分析しています。
企業別
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
イプカ・ラボラトリーズ
杭州ブラザー
連雲港鳳凰バイオファーマ(株)
ラサ・ロボラトリー（Lasa Loboratory
コーデン・ファーマ・ベルガモ
エレジエッレSpA
CTXライフサイエンス
Ishita Active Pharma Ingredients
YCバイオテック(江蘇省)
新郷天豊ファインケミカル
タイプ別セグメント
純度97%以上
純度98%以上
純度99%以上
用途別セグメント
錠剤
カプセル
ペレット・顆粒
坐薬
浣腸
その他
地域別
北アメリカ
アメリカ
カナダ
メキシコ
アジア太平洋
中国
日本
韓国
インド
オーストラリア
SEA
その他のアジア太平洋地域
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
その他のヨーロッパ諸国
南米
ブラジル
アルゼンチン
その他の南米地域
中近東・アフリカ
GCC諸国
イスラエル
イラン
南アフリカ
その他のMEA

ページTOPに戻る

目次

1 STUDY COVERAGE 1
1.1 Mesalazine Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Mesalazine Market Size Growth Rate by Type 2
1.2.2 Purity 鈮97% 3
1.2.3 Purity 鈮98% 3
1.2.4 Purity 鈮99% 4
1.3 Market by Application 4
1.3.1 Global Mesalazine Market Size Growth Rate by Application 4
1.3.2 Mesalazine Drug Information 5
1.3.3 Tablets 6
1.3.4 Capsules 6
1.3.5 Pellet and Granule 7
1.3.6 Suppository 7
1.3.7 Enema 8
1.4 Study Objectives 8
1.5 Years Considered 9
2 EXECUTIVE SUMMARY 10
2.1 Global Mesalazine Market Size Estimates and Forecasts 10
2.1.1 Global Mesalazine Revenue 2016-2027 10
2.1.2 Global Mesalazine Sales 2016-2027 11
2.2 Mesalazine Market Size by Region: 2021 Versus 2027 12
2.3 Mesalazine Sales by Region (2016-2027) 13
2.3.1 Global Mesalazine Sales by Region: 2016-2021 13
2.3.2 Global Mesalazine Sales Forecast by Region (2022-2027) 13
2.3.3 Global Mesalazine Sales Market Share by Region (2016-2027) 14
2.4 Mesalazine Market Estimates and Projections by Region (2022-2027) 14
2.4.1 Global Mesalazine Revenue by Region: 2016-2021 14
2.4.2 Global Mesalazine Revenue Forecast by Region (2022-2027) 15
2.4.3 Global Mesalazine Revenue Market Share by Region (2016-2027) 15
3 GLOBAL MESALAZINE BY MANUFACTURERS 16
3.1 Global Top Mesalazine Manufacturers by Sales 16
3.1.1 Global Mesalazine Sales by Manufacturer (2016-2021) 16
3.1.2 Global Mesalazine Sales Market Share by Manufacturer (2016-2021) 17
3.2 Global Top Mesalazine Manufacturers by Revenue 19
3.2.1 Global Mesalazine Revenue by Manufacturer (2016-2021) 19
3.2.2 Global Mesalazine Revenue Share by Manufacturer (2016-2021) 20
3.3 Global Mesalazine Price by Manufacturer (2016-2021) 22
3.4 Competitive Landscape 22
3.4.1 Key Mesalazine Manufacturers Covered: Ranking by Revenue 22
3.4.2 Global Mesalazine Market Concentration Ratio (CR5 and HHI) & (2016-2021) 23
3.4.3 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 24
3.5 Global Mesalazine Manufacturing Base Distribution, Product Type 25
3.5.1 Mesalazine Manufacturers Manufacturing Base Distribution, Headquarters 25
3.5.2 Manufacturers Mesalazine Product Type 26
3.5.3 Established Date of International Manufacturers in Mesalazine Market 27
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 27
4 COMPANY PROFILES 28
4.1 PharmaZell 28
4.1.1 PharmaZell Corporation Information 28
4.1.2 PharmaZell Description, Business Overview 28
4.1.3 PharmaZell Mesalazine Products Offered 29
4.1.4 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2016-2021) 29
4.1.5 PharmaZell Mesalazine Revenue by Product 29
4.1.6 PharmaZell Mesalazine Revenue by Application 30
4.1.7 PharmaZell Mesalazine Revenue by Geographic Area 30
4.1.8 PharmaZell Mesalazine Revenue by Sales Channel 30
4.1.9 PharmaZell Recent Developments 31
4.2 Syntese A/S 31
4.2.1 Syntese A/S Corporation Information 31
4.2.2 Syntese A/S Description, Business Overview 32
4.2.3 Syntese A/S Mesalazine Products Offered 32
4.2.4 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2016-2021) 33
4.2.5 Syntese A/S Mesalazine Revenue by Product 33
4.2.6 Syntese A/S Mesalazine Revenue by Application 33
4.2.7 Syntese A/S Mesalazine Revenue by Geographic Area 34
4.2.8 Syntese A/S Mesalazine Revenue by Sales Channel 34
4.3 Cambrex Corporation 34
4.3.1 Cambrex Corporation Information 34
4.3.2 Cambrex Corporation Description, Business Overview 35
4.3.3 Cambrex Corporation Mesalazine Products Offered 36
4.3.4 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2016-2021) 37
4.3.5 Cambrex Corporation Mesalazine Revenue by Product 37
4.3.6 Cambrex Corporation Mesalazine Revenue by Application 37
4.3.7 Cambrex Corporation Mesalazine Revenue by Geographic Area 38
4.3.8 Cambrex Corporation Mesalazine Revenue by Sales Channel 38
4.3.9 Cambrex Corporation Recent Developments 38
4.4 Divis Laboratories 39
4.4.1 Divis Laboratories Corporation Information 39
4.4.2 Divis Laboratories Description, Business Overview 39
4.4.3 Divis Laboratories Mesalazine Products Offered 40
4.4.4 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2016-2021) 40
4.4.5 Divis Laboratories Mesalazine Revenue by Product 40
4.4.6 Divis Laboratories Mesalazine Revenue by Application 41
4.4.7 Divis Laboratories Mesalazine Revenue by Geographic Area 41
4.4.8 Divis Laboratories Mesalazine Revenue by Sales Channel 41
4.5 Chemi SpA 42
4.5.1 Chemi SpA Corporation Information 42
4.5.2 Chemi SpA Description, Business Overview 42
4.5.3 Chemi SpA Mesalazine Products Offered 43
4.5.4 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2016-2021) 43
4.5.5 Chemi SpA Mesalazine Revenue by Product 43
4.5.6 Chemi SpA Mesalazine Revenue by Application 44
4.5.7 Chemi SpA Mesalazine Revenue by Geographic Area 44
4.5.8 Chemi SpA Mesalazine Revenue by Sales Channel 44
4.6 Ipca Laboratories 45
4.6.1 Ipca Laboratories Corporation Information 45
4.6.2 Ipca Laboratories Description, Business Overview 45
4.6.3 Ipca Laboratories Mesalazine Products Offered 46
4.6.4 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2016-2021) 46
4.6.5 Ipca Laboratories Mesalazine Revenue by Product 46
4.6.6 Ipca Laboratories Mesalazine Revenue by Application 47
4.6.7 Ipca Laboratories Mesalazine Revenue by Geographic Area 47
4.6.8 Ipca Laboratories Mesalazine Revenue by Sales Channel 47
4.7 Hangzhou Brother 48
4.7.1 Hangzhou Brother Corporation Information 48
4.7.2 Hangzhou Brother Description, Business Overview 48
4.7.3 Hangzhou Brother Mesalazine Products Offered 49
4.7.4 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2016-2021) 49
4.7.5 Hangzhou Brother Mesalazine Revenue by Product 49
4.7.6 Hangzhou Brother Mesalazine Revenue by Application 50
4.7.7 Hangzhou Brother Mesalazine Revenue by Geographic Area 50
4.7.8 Hangzhou Brother Mesalazine Revenue by Sales Channel 50
4.8 Lianyungang Fengheng Biopharm 51
4.8.1 Lianyungang Fengheng Biopharm Corporation Information 51
4.8.2 Lianyungang Fengheng Biopharm Description, Business Overview 51
4.8.3 Lianyungang Fengheng Biopharm Mesalazine Products Offered 52
4.8.4 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2016-2021) 52
4.8.5 Lianyungang Fengheng Biopharm Mesalazine Revenue by Product 52
4.8.6 Lianyungang Fengheng Biopharm Mesalazine Revenue by Application 53
4.8.7 Lianyungang Fengheng Biopharm Mesalazine Revenue by Geographic Area 53
4.8.8 Lianyungang Fengheng Biopharm Mesalazine Revenue by Sales Channel 53
4.9 Lasa Loboratory 54
4.9.1 Lasa Loboratory Corporation Information 54
4.9.2 Lasa Loboratory Description, Business Overview 54
4.9.3 Lasa Loboratory Mesalazine Products Offered 55
4.9.4 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2016-2021) 55
4.9.5 Lasa Loboratory Mesalazine Revenue by Product 56
4.9.6 Lasa Loboratory Mesalazine Revenue by Application 56
4.9.7 Lasa Loboratory Mesalazine Revenue by Geographic Area 56
4.9.8 Lasa Loboratory Mesalazine Revenue by Sales Channel 57
4.10 Corden Pharma Bergamo 57
4.10.1 Corden Pharma Bergamo Corporation Information 57
4.10.2 Corden Pharma Bergamo Description, Business Overview 57
4.10.3 Corden Pharma Bergamo Mesalazine Products Offered 58
4.10.4 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2016-2021) 58
4.10.5 Corden Pharma Bergamo Mesalazine Revenue by Product 58
4.10.6 Corden Pharma Bergamo Mesalazine Revenue by Application 59
4.10.7 Corden Pharma Bergamo Mesalazine Revenue by Geographic Area 59
4.10.8 Corden Pharma Bergamo Mesalazine Revenue by Sales Channel 59
4.10.9 Corden Pharma Bergamo Recent Developments 60
4.11 Erregierre SpA 60
4.11.1 Erregierre SpA Corporation Information 60
4.11.2 Erregierre SpA Description, Business Overview 60
4.11.3 Erregierre SpA Mesalazine Products Offered 61
4.11.4 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2016-2021) 61
4.11.5 Erregierre SpA Mesalazine Revenue by Product 61
4.11.6 Erregierre SpA Mesalazine Revenue by Application 62
4.11.7 Erregierre SpA Mesalazine Revenue by Geographic Area 62
4.11.8 Erregierre SpA Mesalazine Revenue by Sales Channel 62
4.12 CTX Lifescience 63
4.12.1 CTX Lifescience Corporation Information 63
4.12.2 CTX Lifescience Description, Business Overview 63
4.12.3 CTX Lifescience Mesalazine Products Offered 64
4.12.4 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2016-2021) 64
4.12.5 CTX Lifescience Mesalazine Revenue by Product 64
4.12.6 CTX Lifescience Mesalazine Revenue by Application 65
4.12.7 CTX Lifescience Mesalazine Revenue by Geographic Area 65
4.12.8 CTX Lifescience Mesalazine Revenue by Sales Channel 65
4.13 Ishita Active Pharma Ingredients 65
4.13.1 Ishita Active Pharma Ingredients Corporation Information 65
4.13.2 Ishita Active Pharma Ingredients Description, Business Overview 66
4.13.3 Ishita Active Pharma Ingredients Mesalazine Products Offered 66
4.13.4 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2016-2021) 67
4.13.5 Ishita Active Pharma Ingredients Mesalazine Revenue by Product 67
4.13.6 Ishita Active Pharma Ingredients Mesalazine Revenue by Application 67
4.13.7 Ishita Active Pharma Ingredients Mesalazine Revenue by Geographic Area 68
4.13.8 Ishita Active Pharma Ingredients Mesalazine Revenue by Sales Channel 68
4.14 YC Biotech (Jiangsu) 68
4.14.1 YC Biotech (Jiangsu) Corporation Information 68
4.14.2 YC Biotech (Jiangsu) Description, Business Overview 69
4.14.3 YC Biotech (Jiangsu) Mesalazine Products Offered 69
4.14.4 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2016-2021) 70
4.14.5 YC Biotech (Jiangsu) Mesalazine Revenue by Product 70
4.14.6 YC Biotech (Jiangsu) Mesalazine Revenue by Application 70
4.14.7 YC Biotech (Jiangsu) Mesalazine Revenue by Geographic Area 70
4.14.8 YC Biotech (Jiangsu) Mesalazine Revenue by Sales Channel 71
4.15 Xinxiang Tianfeng Fine Chemical 71
4.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information 71
4.15.2 Xinxiang Tianfeng Fine Chemical Description, Business Overview 71
4.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Products Offered 72
4.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2016-2021) 72
4.15.5 Xinxiang Tianfeng Fine Chemical Mesalazine Revenue by Product 73
4.15.6 Xinxiang Tianfeng Fine Chemical Mesalazine Revenue by Application 73
4.15.7 Xinxiang Tianfeng Fine Chemical Mesalazine Revenue by Geographic Area 73
4.15.8 Xinxiang Tianfeng Fine Chemical Mesalazine Revenue by Sales Channel 73
5 BREAKDOWN DATA BY TYPE 74
5.1 Global Mesalazine Sales by Type (2016-2027) 74
5.1.1 Global Mesalazine Sales by Type (2016-2021) 74
5.1.2 Global Mesalazine Sales Forecast by Type (2022-2027) 74
5.1.3 Global Mesalazine Sales Market Share by Type (2016-2027) 75
5.2 Global Mesalazine Revenue Forecast by Type (2016-2027) 75
5.2.1 Global Mesalazine Revenue by Type (2016-2021) 75
5.2.2 Global Mesalazine Revenue Forecast by Type (2022-2027) 76
5.2.3 Global Mesalazine Revenue Market Share by Type (2016-2027) 76
5.3 Mesalazine Average Selling Price (ASP) by Type (2016-2027) 77
6 BREAKDOWN DATA BY APPLICATION 78
6.1 Global Mesalazine Sales by Application (2016-2027) 78
6.1.1 Global Mesalazine Sales by Application (2016-2021) 78
6.1.2 Global Mesalazine Sales Forecast by Application (2022-2027) 78
6.1.3 Global Mesalazine Sales Market Share by Application (2016-2027) 79
6.2 Global Mesalazine Revenue Forecast by Application (2016-2027) 79
6.2.1 Global Mesalazine Revenue by Application (2016-2021) 79
6.2.2 Global Mesalazine Revenue Forecast by Application (2022-2027) 80
6.2.3 Global Mesalazine Revenue Market Share by Application (2016-2027) 80
6.3 Mesalazine Average Selling Price (ASP) by Application (2016-2027) 81
7 NORTH AMERICA 82
7.1 North America Mesalazine Market Size YoY Growth 2016-2027 82
7.2 North America Mesalazine Market Facts & Figures by Country 82
7.2.1 North America Mesalazine Sales by Country (2016-2027) 82
7.2.2 North America Mesalazine Revenue by Country (2016-2027) 83
7.3 North America Mesalazine Sales by Type 84
7.4 North America Mesalazine Sales by Application 85
8 ASIA-PACIFIC 86
8.1 Asia-Pacific Mesalazine Market Size YoY Growth 2016-2027 86
8.2 Asia-Pacific Mesalazine Market Facts & Figures by Region 86
8.2.1 Asia-Pacific Mesalazine Sales by Region (2016-2027) 86
8.2.2 Asia-Pacific Mesalazine Revenue by Region (2016-2027) 88
8.3 Asia-Pacific Mesalazine Sales by Type 89
8.4 Asia-Pacific Mesalazine Sales by Application 90
9 EUROPE 91
9.1 Europe Mesalazine Market Size YoY Growth 2016-2027 91
9.2 Europe Mesalazine Market Facts & Figures by Country 91
9.2.1 Europe Mesalazine Sales by Country (2016-2027) 91
9.2.2 Europe Mesalazine Revenue by Country (2016-2027) 93
9.3 Europe Mesalazine Sales by Type 94
9.4 Europe Mesalazine Sales by Application 95
10 SOUTH AMERICA 96
10.1 South America Mesalazine Market Size YoY Growth 2016-2027 96
10.2 South America Mesalazine Market Facts & Figures by Country 96
10.2.1 South America Mesalazine Sales by Country (2016-2027) 96
10.2.2 South America Mesalazine Revenue by Country (2016-2027) 98
10.3 South America Mesalazine Sales by Type 99
10.4 South America Mesalazine Sales by Application 100
11 MIDDLE EAST AND AFRICA 101
11.1 South America Mesalazine Market Size YoY Growth 2016-2027 101
11.2 Middle East and Africa Mesalazine Market Facts & Figures by Country 101
11.2.1 Middle East and Africa Mesalazine Sales by Country (2016-2027) 101
11.2.2 Middle East and Africa Mesalazine Revenue by Country (2016-2027) 103
11.3 Middle East and Africa Mesalazine Sales by Type 104
11.4 Middle East and Africa Mesalazine Sales by Application 105
12 SUPPLY CHAIN AND SALES CHANNEL ANALYSIS 106
12.1 Mesalazine Supply Chain Analysis 106
12.2 Mesalazine Key Raw Materials and Upstream Suppliers 106
12.3 Manufacturing Process Analysis of Mesalazine 107
12.4 Mesalazine Clients Analysis 108
12.5 Mesalazine Sales Channel and Sales Model Analysis 109
12.5.1 Mesalazine Distribution Channel Analysis: Indirect Sales VS Direct Sales 110
12.5.2 Mesalazine Distribution Channel Analysis: Online Sales VS Offline Sales 110
12.5.3 Mesalazine Distributors 111
13 MESALAZINE MARKET DYNAMICS 112
13.1 Mesalazine Industry Trends 112
13.2 Mesalazine Market Opportunities and Drivers 112
13.3 Mesalazine Market Challenges 113
14 RESEARCH FINDINGS AND CONCLUSION 114
15 APPENDIX 115
15.1 Research Methodology 115
15.1.1 Methodology/Research Approach 115
15.1.2 Data Source 118
15.2 Author Details 121
15.3 Disclaimer 121